Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overall Response Rate”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Testing effectiveness (Phase 2)Study completedNCT01893372
What this trial is testing

Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Ended earlyNCT01466868
What this trial is testing

Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Centre Leon Berard 22
Not applicableUnknownNCT03892577
What this trial is testing

Real-world Study for Patients With Advanced Hepatobiliary Tumors

Who this might be right for
Objective Response RateProgression-free SurvivalOverall Survival+4 more
Peking Union Medical College Hospital 3,000
Not applicableStudy completedNCT02603315
What this trial is testing

Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)

Who this might be right for
Malignant Pleural Mesotheliomas
Ain Shams University 50
Testing effectiveness (Phase 2)Study completedNCT02383498
What this trial is testing

QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma

Who this might be right for
Chordoma
NantCell, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01323400
What this trial is testing

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
GIST
Centre Leon Berard 81
Not applicableLooking for participantsNCT05749627
What this trial is testing

Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
The First Affiliated Hospital of Nanchang University 20
Testing effectiveness (Phase 2)Looking for participantsNCT07448142
What this trial is testing

Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer (CRC)
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Ended earlyNCT02504892
What this trial is testing

Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer

Who this might be right for
Renal CancerBirt-Hogg-Dube Syndrome
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT02460276
What this trial is testing

A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma

Who this might be right for
Relapsed/Refractory Mantle Cell Lymphoma
Lund University Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00109005
What this trial is testing

Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05114746
What this trial is testing

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 94
Testing effectiveness (Phase 2)Study completedNCT00436241
What this trial is testing

Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 45
Testing effectiveness (Phase 2)Temporarily pausedNCT00568529
What this trial is testing

Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 30
Testing effectiveness (Phase 2)UnknownNCT04664244
What this trial is testing

Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma

Who this might be right for
Recurrent Cervical CarcinomaRadiotherapyEpidermal Growth Factor Receptor+4 more
Lei Li 43
Testing effectiveness (Phase 2)Study completedNCT00475423
What this trial is testing

MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Hoffmann-La Roche 122
Not applicableUnknownNCT03336554
What this trial is testing

Epigenetic Biomarker for Osteosarcoma

Who this might be right for
Histologic Response (Tumor Necrosis Rate)Objective Response Rate for Neoadjuvant Chemotherapy, ORRProgression-free Survival, PFS+1 more
Peking University People's Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT06520345
What this trial is testing

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 430
Testing effectiveness (Phase 2)Looking for participantsNCT06530576
What this trial is testing

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

Who this might be right for
T-LGL LeukemiaNK-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 48
Testing effectiveness (Phase 2)Looking for participantsNCT07090525
What this trial is testing

Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions

Who this might be right for
Overall Response Rate
Qingdao Central Hospital 60
Load More Results